增强计算机断层扫描特征可预测Ki-67指数低于5%的胰腺神经内分泌肿瘤
本研究纳入142例病理诊断为胰腺神经内分泌肿瘤且有术前多期增强CT的患者,按Ki-67指数5%为界分为低指数组(1%-5%,104例)和高指数组(>5%,38例)。结果显示肿瘤直径、边缘、远端主胰管扩张、血管受累及动脉期低强化等CT特征在两组间有显著差异,多因素逻辑回归模型AUC为0.853,提示术前增强CT有助于鉴别Ki-67指数>5%的非转移性胰腺神经内分泌肿瘤。
要点
- 直径较大、边缘不清、远端主胰管扩张及动脉期低强化提示Ki-67指数>5%。
- 多因素逻辑回归模型鉴别Ki-67≤5%与>5%的AUC为0.853。
- 甲胎蛋白和癌抗原125在两组间差异有统计学意义(P=0.030和P=0.049)。
核心结论
- 非转移性胰腺神经内分泌肿瘤若术前增强CT表现为直径较大、边缘不清、远端主胰管扩张及动脉期低强化,则倾向于Ki-67指数>5%。
研究设计与样本
- 研究纳入病理诊断为胰腺神经内分泌肿瘤且有术前多期增强CT的患者142例,按Ki-67指数5%为界分为低指数组(1%-5%,104例)和高指数组(>5%,38例),比较两组CT特征及血清生物标志物。
关键影像表现/征象
- 肿瘤直径在低指数组与高指数组间差异有统计学意义(P<0.0001)。
- 肿瘤边缘在两组间差异有统计学意义(P=0.003)。
- 远端主胰管扩张在两组间差异有统计学意义(P=0.021)。
- 血管受累在两组间差异有统计学意义(P=0.002)。
- 动脉期低强化和门静脉期低强化在两组间差异均有统计学意义(P<0.0001和P=0.003)。
诊断标准与关键数值
- 以Ki-67指数5%为界分组,低指数组为1%-5%,高指数组为>5%。
- 多因素逻辑回归模型鉴别两组AUC为0.853。
- 甲胎蛋白在两组间差异P=0.030,癌抗原125在两组间差异P=0.049。
- 动脉期比值在两组间差异P=0.0001,门静脉期比值在两组间差异P=0.0003。
临床应用与阅片要点
- 术前增强CT示肿瘤直径较大、边缘不清、远端主胰管扩张及动脉期低强化时,提示Ki-67指数可能>5%。
- 作者认为该结果为临床医生决定是否手术提供了替代方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Several studies have suggested that patients with pancreatic neuroendocrine neoplasm (pNEN) with the Ki-67 index of < 5% are more likely to show better prognosis after clinical intervention. Moreover, the Ki-67 index at 5% has also been suggested as a potential threshold by the 2016 European Neuroendocrine Tumor Society guidelines.
OBJECTIVE: Based on preoperative enhanced computed tomography (CT), this study aimed to investigate imaging characteristics eligible to discriminate the ≤ 5% Ki-67 group from the > 5% Ki-67 group of patients with nonmetastatic pNEN.
METHODS: Patients with pathologically diagnosed pNEN and preoperative multiphase CT were enrolled. Their Ki-67 index was calculated and grouped according to the 5% cutoff value. The following CT imaging characteristics and some serum biomarkers were assessed between the two groups: the diameter, location, tumor margin, calcification, pancreatic atrophy, distal pancreatic duct dilation, vessel involvement, and enhancement pattern characteristics of both arterial phase (AP) and portal vein phase (PVP).
RESULTS: A total of 142 patients with pNEN were enrolled in this study, comprising 104 in the low (Ki-67, 1%-5%) and 38 in the high index group (Ki-67, >5%). Alpha fetoprotein and cancer antigen 125 were significantly different between the two groups (P-values, 0.030 and 0.049, respectively). The diameter (P < 0.0001), margin (P = 0.003), distal main ductal dilation (P = 0.021), vessel involvement (P = 0.002), AP hypoenhancement (P < 0.0001), PVP hypoenhancement (P = 0.003), AP ratio (P = 0.0001), and PVP ratio (P = 0.0003) were significantly different between the low and high index groups. The area under the curve of the multivariate logistic regression model was 0.853.
CONCLUSION: Nonmetastatic pNENs with larger diameter, ill-defined margin, distal main ductal dilation, and tumor hypoenhancement in AP in preoperative enhanced CT tend to have a Ki-67 index of > 5%.The results of this study provide an alternative method to clinicians to decide whether surgery is appropriate.
引用
- Yu, Li, Cao, et al. Enhanced computed tomography features predict pancreatic neuroendocrine neoplasm with Ki-67 index less than 5. Eur J Radiol. 2021. PMID: 34972060. doi:10.1016/j.ejrad.2021.110100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。